The Biology of Cancer:
Microenvironment, Metastasis & Therapeutics
April 26 - 30, 2011
Abstract Deadline: February 4, 2011

Organizers:
Senthil Muthuswamy, Ontario Cancer Institute, Canada
Kornelia Polyak, Dana Farber Cancer Institute
David Tuveson, Cambridge Research Institute, UK

You are cordially invited to participate in a new meeting on The Biology of Cancer: Microenvironment, Metastasis & Therapeutics to be held at Cold Spring Harbor Laboratory, New York. The meeting will begin on Tuesday, April 26, 2011, and will conclude with lunch on Saturday, April 30. The specific goal of this conference is to bring together a diverse group of scientists studying various aspects of the biology of cancer. The meeting will alternate annually with the CSHL meeting on Mechanisms & Models of Cancer.

The format of the meeting will include morning and evening sessions consisting of eight or nine 15-minute talks per session, selected from the abstracts, principally on unpublished work. In addition, there will be two poster sessions, held in the afternoons. The organizers will decide the suitability of each abstract for oral or poster presentation, but please specify if you prefer a poster.  

Keynote Speaker:
Charles Sawyers
HHMI/Memorial Sloan Kettering Cancer Center

Topics & Speakers Include:
Integrated discovery platforms and personalized medicine
Alan Ashworth, Breakthrough Breast Cancer Res. Centre, UK
David Epstein, OSI Pharmaceuticals
Judy Garber, Dana Farber Cancer Institute
Raghu Kalluri, Harvard Medical School
Ashok Venkitaraman, Hutchison/MRC Research Centre, UK

Cancer cell metabolism
Chi Dang, Johns Hopkins University School of Medicine
Tak Mak, Ontario Cancer Institute, Canada
M. Celeste Simon, University of Pennsylvania Medical School
Craig Thompson, University of Pennsylvania

Tumor heterogeneity and cancer cell plasticity
John Dick, Toronto General Research Institute, Canada
Meenhard Herlyn, The Wistar Institute
Sean Morrison, University of Michigan
Robert Weinberg, Whitehead Institute for Biomedical Research

Genetics and biology of tumor cell architecture
Patrick Humbert, Peter MacCallum Cancer Institute, Australia
Ian Macara, University of Virginia School of Medicine
Valerie Weaver, University of California San Francisco
Valeri Vasioukhin, Fred Hutchinson Cancer Research Center

Modeling cancer in mice: xenograft and genetically engineered models
Lynda Chin, Dana Farber Cancer Institute
Gerard Evan, University of Cambridge, UK
Jos Jonkers, Netherlands Cancer Institute, The Netherlands
Scott Lowe, Cold Spring Harbor Laboratory/HHMI
Benjamin Neel, Ontario Cancer Institute, Canada

Molecular imaging and Targeted drug delivery
Kevin Brindle, University of Cambridge, UK
Mauro Ferrari, University of Texas, Houston
Zena Werb, University of California, San Francisco

Tumor immunology
Pamela Ohashi, Ontario Research Institute, Canada
Douglas Fearon, University of Cambridge, UK
James Allison, HHMI/Memorial Sloan Kettering Cancer Center
Steven Rosenberg, National Cancer Institute

Tumor-stroma interactions–inflammation
Mina Bissell, Lawrence Berkeley National Laboratory
Lisa Coussens, University of California, San Francisco
Michael Karin, University of California, San Diego
Joan Massague, Memorial Sloan Kettering Cancer Center

Abstracts should contain only new and unpublished material and must be submitted electronically by the abstract deadline. Selection of material for oral and poster presentation will be made by the organizers and individual session chairs. Status (talk/poster) of abstracts will be posted on our web site as soon as decisions have been made by the organizers.

We are eager to have as many young people as possible attend since they are likely to benefit most from this meeting. We have applied for funds from government and industry to partially support graduate students and postdocs. Apply in writing to meetings@cshl.edu stating need for financial support - preference is given to those submitting abstracts.

We look forward to seeing you at Cold Spring Harbor in April.

Major support for this conference is provided by:
OSI Pharmaceuticals, part of Astellas Pharma Inc.
Additional support for this conference may be provided by:
National Cancer Institute, Molecular Devices and Applied Biophysics

We have funds to provide partial scholarships for individuals who are US citizens/permanent residents from minority groups under-represented in the life sciences. Please provide justification in writing to meetings@cshl.edu and state your financial needs. Preference will be given to those applying who submit abstracts to the meeting.

---

Regular packages are all inclusive and cover registration, food, housing, parking, wine-and-cheese party, lobster banquet, etc. No Housing packages include all costs except housing. Full payment is due 4 weeks prior to the meeting.